| 2018 |
| 09/03 | 15:00 第三者割当による第13回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ |
| 09/03 | 15:00 日本癌学会学術総会における発表のお知らせ |
| 08/30 | 997 | 1,035 | 964 | 1,012 | +1.2% | 1,985,500 | 103億2756万 | +30.92% |
| 08/29 | 1,155 | 1,167 | 992 | 1,000 | -6.1% | 7,023,000 | 102億510万 | +31.06% |
| 08/28 | 1,065 | 1,065 | 1,065 | 1,065 | +16.39% | 57,400 | 108億6843万 | +41.06% |
| 08/27 | 915 | 915 | 915 | 915 | +19.61% | 22,200 | 93億3766万 | +23.15% |
| 08/27 | 8:30 武田薬品工業との技術ライセンス契約締結のお知らせ |
| 08/24 | 759 | 778 | 744 | 765 | +2.82% | 161,400 | 78億690万 | +3.66% |
| 08/23 | 716 | 758 | 716 | 744 | +4.49% | 133,300 | 75億9259万 | +0.81% |
| 08/22 | 700 | 731 | 700 | 712 | +1.86% | 185,400 | 72億6603万 | -3.39% |
| 08/21 | 695 | 710 | 686 | 699 | -0.29% | 77,900 | 71億3056万 | -5.41% |
| 08/20 | 711 | 734 | 699 | 701 | -2.09% | 116,600 | 71億5097万 | -5.27% |
| 08/17 | 708 | 730 | 708 | 716 | +3.62% | 75,700 | 73億398万 | -3.63% |
| 08/16 | 681 | 703 | 678 | 691 | -0.14% | 93,800 | 70億4896万 | -7.25% |
| 08/15 | 714 | 725 | 691 | 692 | -3.08% | 122,200 | 70億5916万 | -7.36% |
| 08/14 | 703 | 724 | 688 | 714 | +1.28% | 142,800 | 72億8358万 | -4.93% |
| 08/13 | 687 | 714 | 680 | 705 | -0.7% | 155,800 | 71億9177万 | -6.5% |
| 08/10 | 16:30 (数値データ訂正)「平成30年12月期第2四半期決算短信〔日本基準〕(連結)」におけるXBRLデータの一部訂正について |
| 08/10 | 15:00 第2四半期(累計)連結業績予想と実績値との差異及び平成30年12月期通期連結業績予想の修正に関するお知らせ |
| 08/10 | 15:00 平成30年12月期第2四半期決算短信〔日本基準〕(連結) |
| 08/10 | 717 | 730 | 703 | 710 | -3.92% | 74,500 | 72億4278万 | -6.21% |
| 08/09 | 711 | 744 | 711 | 739 | +4.53% | 150,000 | 75億3861万 | -2.51% |
| 08/08 | 690 | 711 | 684 | 707 | +0.57% | 108,300 | 72億1217万 | -6.85% |
| 08/07 | 716 | 721 | 691 | 703 | -1.68% | 127,600 | 71億7137万 | -7.74% |
| 08/06 | 733 | 738 | 715 | 715 | -3.51% | 150,400 | 72億9378万 | -6.54% |
| 08/03 | 767 | 767 | 736 | 741 | -3.39% | 139,200 | 75億5901万 | -3.64% |
| 08/02 | 769 | 782 | 765 | 767 | -0.52% | 76,000 | 78億2424万 | -0.65% |
| 08/01 | 15:00 第三者割当による第13回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ |
| 08/01 | 770 | 772 | 753 | 771 | +0.65% | 81,200 | 78億6504万 | -0.39% |
| 07/31 | 763 | 767 | 746 | 766 | +0.13% | 88,300 | 78億1404万 | -1.16% |
| 07/30 | 791 | 791 | 758 | 765 | -4.14% | 182,500 | 78億384万 | -1.42% |
| 07/27 | 794 | 803 | 774 | 798 | +2.05% | 105,000 | 81億4047万 | +2.57% |
| 07/26 | 793 | 811 | 760 | 782 | -1.64% | 280,100 | 79億7726万 | +0.13% |
| 07/25 | 775 | 818 | 766 | 795 | +2.98% | 194,000 | 81億987万 | +1.4% |
| 07/24 | 775 | 793 | 754 | 772 | +0.13% | 133,400 | 78億7524万 | -1.78% |
| 07/23 | 750 | 776 | 741 | 771 | +1.05% | 130,200 | 78億6504万 | -2.41% |
| 07/20 | 745 | 770 | 738 | 763 | +3.39% | 167,900 | 77億8343万 | -4.03% |
| 07/19 | 783 | 787 | 735 | 738 | -3.15% | 255,400 | 75億2841万 | -7.87% |
| 07/18 | 15:00 アルツハイマー治療貼付剤MRX-7MLL非臨床試験開始のお知らせ |
| 07/18 | 725 | 766 | 723 | 762 | +5.54% | 223,800 | 77億7323万 | -5.69% |
| 07/17 | 765 | 766 | 718 | 722 | -6.23% | 338,600 | 73億6519万 | -11.41% |
| 07/13 | 776 | 789 | 764 | 770 | +1.18% | 137,200 | 78億5484万 | -6.33% |
| 07/12 | 760 | 774 | 754 | 761 | +0.53% | 109,900 | 77億6303万 | -8.09% |
| 07/11 | 777 | 802 | 749 | 757 | -1.69% | 227,200 | 77億2223万 | -9.77% |
| 07/10 | 802 | 807 | 769 | 770 | -4.7% | 210,900 | 78億5484万 | -8.77% |
| 07/09 | 778 | 809 | 766 | 808 | +4.66% | 249,100 | 82億4248万 | -4.83% |
| 07/06 | 747 | 773 | 735 | 772 | +5.46% | 196,200 | 78億7524万 | -9.39% |
| 07/05 | 772 | 788 | 729 | 732 | -5.79% | 255,100 | 74億6720万 | -14.69% |
| 07/04 | 759 | 786 | 751 | 777 | +1.57% | 156,600 | 79億2625万 | -10.38% |
| 07/03 | 784 | 800 | 755 | 765 | -3.65% | 306,800 | 78億384万 | -12.27% |
| 07/02 | 15:00 第三者割当による第13回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ |
| 07/02 | 802 | 815 | 791 | 794 | -1.73% | 101,600 | 80億9967万 | -9.67% |
| 06/29 | 802 | 830 | 794 | 808 | +0.62% | 124,800 | 82億4248万 | -8.8% |
| 06/28 | 810 | 823 | 788 | 803 | -2.07% | 209,500 | 81億9148万 | -10.08% |
| 06/27 | 801 | 821 | 795 | 820 | +1.23% | 147,100 | 83億6490万 | -9.09% |
| 06/26 | 775 | 811 | 767 | 810 | +3.98% | 301,100 | 82億6289万 | -11.09% |
| 06/25 | 830 | 845 | 774 | 779 | -5.8% | 371,700 | 79億4665万 | -15.42% |
| 06/22 | 843 | 850 | 820 | 827 | -4.06% | 145,900 | 84億3630万 | -11.27% |
| 06/21 | 870 | 888 | 850 | 862 | 0% | 151,900 | 87億3326万 | -8.59% |
| 06/20 | 825 | 868 | 800 | 862 | +3.23% | 313,500 | 87億3326万 | -9.36% |
| 06/19 | 876 | 881 | 814 | 835 | -5.11% | 429,300 | 84億5971万 | -12.84% |
| 06/18 | 904 | 904 | 857 | 880 | -3.19% | 327,300 | 89億1563万 | -9% |
| 06/15 | 902 | 923 | 902 | 909 | +0.11% | 120,300 | 92億944万 | -6.67% |
| 06/14 | 906 | 920 | 904 | 908 | -0.44% | 107,100 | 91億9931万 | -7.35% |
| 06/13 | 920 | 921 | 901 | 912 | -0.98% | 194,900 | 92億3983万 | -7.69% |
| 06/12 | 906 | 921 | 898 | 921 | +1.66% | 240,600 | 93億3101万 | -7.53% |
| 06/11 | 924 | 942 | 906 | 906 | -2.79% | 340,600 | 91億7904万 | -9.85% |
| 06/08 | 1,033 | 1,035 | 928 | 932 | -9.78% | 2,125,200 | 94億4246万 | -8.09% |
| 06/07 | 1,000 | 1,033 | 977 | 1,033 | +16.99% | 602,900 | 104億6573万 | +1.08% |
| 06/06 | 15:00 MRX-5LBTの生物学的同等性を示す検証的臨床試験結果のお知らせ |
| 06/06 | 879 | 899 | 863 | 883 | +0.46% | 167,000 | 89億4602万 | -13.85% |
| 06/05 | 885 | 896 | 860 | 879 | -2.33% | 335,400 | 89億550万 | -15.07% |
| 06/04 | 926 | 928 | 885 | 900 | -2.6% | 254,900 | 91億1826万 | -14.04% |
| 06/01 | 15:00 第三者割当による第13回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ |
| 06/01 | 927 | 952 | 917 | 924 | -1.7% | 122,500 | 93億6141万 | -12.67% |
| 05/31 | 926 | 941 | 922 | 940 | +2.4% | 95,900 | 95億2351万 | -11.82% |
| 05/30 | 900 | 941 | 897 | 918 | -0.33% | 269,700 | 93億62万 | -14.6% |
| 05/29 | 975 | 981 | 910 | 921 | -6.02% | 496,700 | 93億3101万 | -15.12% |
| 05/28 | 983 | 1,013 | 977 | 980 | -0.2% | 245,200 | 99億2877万 | -10.42% |
| 05/25 | 1,020 | 1,026 | 975 | 982 | -4.1% | 498,300 | 99億4903万 | -10.89% |
| 05/24 | 1,052 | 1,060 | 1,017 | 1,024 | -2.94% | 357,300 | 103億7455万 | -7.66% |
| 05/23 | 1,061 | 1,090 | 1,051 | 1,055 | -0.28% | 184,400 | 106億8862万 | -5.38% |
| 05/22 | 1,053 | 1,079 | 1,034 | 1,058 | 0% | 259,800 | 107億1902万 | -5.79% |
| 05/21 | 1,065 | 1,079 | 1,052 | 1,058 | -2.4% | 230,500 | 106億4496万 | -6.54% |
| 05/18 | 1,073 | 1,117 | 1,059 | 1,084 | +0.28% | 334,400 | 109億655万 | -5% |
| 05/17 | 1,041 | 1,086 | 1,041 | 1,081 | +4.14% | 132,700 | 108億7637万 | -7.21% |
| 05/16 | 1,028 | 1,043 | 1,020 | 1,038 | -1.52% | 394,600 | 104億4373万 | -12.92% |
| 05/15 | 1,068 | 1,068 | 1,042 | 1,054 | -0.75% | 182,500 | 106億471万 | -13.61% |
| 05/14 | 1,073 | 1,105 | 1,055 | 1,062 | +1.53% | 409,900 | 106億8520万 | -14.84% |
| 05/11 | 15:00 平成30年12月期第1四半期決算短信〔日本基準〕(連結) |
| 05/11 | 1,092 | 1,098 | 1,029 | 1,046 | -5.51% | 599,000 | 105億2422万 | -17.96% |
| 05/10 | 1,095 | 1,122 | 1,079 | 1,107 | +0.36% | 385,500 | 111億3796万 | -15.43% |
| 05/09 | 1,145 | 1,149 | 1,102 | 1,103 | -3.67% | 396,400 | 110億9772万 | -17.81% |
| 05/08 | 1,138 | 1,155 | 1,127 | 1,145 | +1.24% | 331,500 | 115億2030万 | -16.61% |
| 05/07 | 15:00 マイクロニードル国際学会での発表に関するお知らせ |
| 05/07 | 1,105 | 1,140 | 1,100 | 1,131 | -0.62% | 286,600 | 113億7944万 | -19.5% |
| 05/02 | 1,094 | 1,145 | 1,091 | 1,138 | +2.52% | 231,000 | 114億4987万 | -20.86% |
| 05/01 | 1,130 | 1,144 | 1,090 | 1,110 | -2.72% | 525,200 | 111億6815万 | -24.34% |
| 04/27 | 12:00 第三者割当による第13回新株予約権(行使価額修正条項付)の発行価額の払込完了に関するお知らせ |
| 04/27 | 1,166 | 1,199 | 1,127 | 1,141 | -3.88% | 481,300 | 114億8005万 | -23.88% |
| 04/26 | 1,168 | 1,206 | 1,147 | 1,187 | +1.45% | 739,700 | 119億4288万 | -22.52% |
| 04/25 | 15:00 第12回新株予約権の取得及び消却完了に関するお知らせ |
| 04/25 | 1,130 | 1,185 | 1,116 | 1,170 | +4.19% | 453,400 | 117億7183万 | -25.24% |
| 04/24 | 1,158 | 1,169 | 1,117 | 1,123 | -2.43% | 459,200 | 112億9895万 | -29.68% |
| 04/23 | 1,139 | 1,176 | 1,133 | 1,151 | -1.54% | 269,400 | 115億8067万 | -29.3% |
| 04/20 | 1,128 | 1,196 | 1,122 | 1,169 | +0.95% | 382,500 | 111億7528万 | -29.62% |
| 04/19 | 1,141 | 1,168 | 1,111 | 1,158 | -0.43% | 553,900 | 110億7013万 | -31.72% |
| 04/18 | 1,169 | 1,194 | 1,135 | 1,163 | -1.11% | 388,600 | 111億1793万 | -32.89% |
| 04/17 | 1,181 | 1,197 | 1,124 | 1,176 | +0.43% | 952,600 | 112億4220万 | -33.26% |
| 04/16 | 1,257 | 1,269 | 1,164 | 1,171 | -5.64% | 807,200 | 111億9440万 | -34.54% |
| 04/13 | 1,255 | 1,264 | 1,200 | 1,241 | -3.12% | 1,072,500 | 118億6358万 | -31.78% |
| 04/12 | 12:00 マイクロニードルアレイ事業についての補足説明 |
| 04/12 | 1,311 | 1,359 | 1,254 | 1,281 | -1.31% | 1,076,200 | 122億4597万 | -30.42% |
| 04/11 | 15:00 第11回新株予約権の行使完了に関するお知らせ |
| 04/11 | 1,500 | 1,506 | 1,288 | 1,298 | -23.1% | 3,053,900 | 124億849万 | -30.25% |
| 04/10 | 15:00 第11回及び第12回新株予約権の取得及び消却に関するお知らせ |
| 04/10 | 15:00 第三者割当による第13回新株予約権(行使価額修正条項付)の発行及び第三者割当契約の締結に関するお知らせ |
| 04/10 | 1,731 | 1,744 | 1,680 | 1,688 | -3.21% | 417,900 | 161億3677万 | -10.12% |
| 04/09 | 1,718 | 1,775 | 1,700 | 1,744 | -0.23% | 179,600 | 166億7211万 | -7.09% |
